|
Genzyme to Build R&D Center in Beijing
April 22, 2008—Genzyme plans
 a
new Chinese facility for research and development activities
involving many of Genzyme's key areas of focus, including
orthopedics, transplant and immune disease, oncology,
endocrinology and cardiovascular disease. The facility, which
will feature an innovative green design, will also include
laboratory-scale operations for the MACI (matrix-induced
autologous chondrocyte implantation) cell therapy and polyclonal
antibody operations.
Genzyme
|
